FundedIQ
Biotechnology

Seamless Therapeutics: Funding, Investors & Team (Sep 2026)

Seamless Therapeutics is revolutionizing gene editing by introducing a novel method to safely and accurately improve the health of patients with serious conditions. The Seamless technology platform facilitates the regulation of recombinases, a type of enzyme that offers enormous flexibility.

seamlesstx.com LinkedIn Dresden, Germany 11-50 employees
Genetics Therapeutics B2B
Total raised
$12.5M
Rounds
1
Latest
Seed
Mar 2023

Seamless Therapeutics has raised $12.5M across 1 funding round on record, the most recent a Seed of $12.5M announced in Mar 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Seamless Therapeutics Company Profile and Key Stats

Total funding raised
$12.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$12.5M in Mar 2023
Employees
11-50
reported band
Headquarters
Dresden, Germany

Latest funding round on record: Mar 2023.

Seamless Therapeutics Funding Rounds

Date
Round
Amount
Seed
$12.5M

Seamless Therapeutics Founders and Leadership Team

Name
Role
Contact
Felix Lansing
Founder
Locked

Contact details for the Seamless Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Seamless Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
1,812
$6.5M
16,485
$3.1M

Seamless Therapeutics' latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Seamless Therapeutics in Biotechnology and Dresden

Companies Similar to Seamless Therapeutics

Seamless Therapeutics Funding FAQs

What does Seamless Therapeutics do?

Seamless Therapeutics is revolutionizing gene editing by introducing a novel method to safely and accurately improve the health of patients with serious conditions. The Seamless technology platform facilitates the regulation of recombinases, a type of enzyme that offers enormous flexibility.

How much funding has Seamless Therapeutics raised?

Seamless Therapeutics has raised $12.5M across 1 round on record. The most recent is a Seed of $12.5M announced in Mar 2023.

When did Seamless Therapeutics last raise funding?

Seamless Therapeutics' most recent funding round on record is a Seed of $12.5M, announced in Mar 2023.

Who founded Seamless Therapeutics?

FundedIQ lists Felix Lansing (Founder) at Seamless Therapeutics.

Where is Seamless Therapeutics headquartered?

Seamless Therapeutics is based in Dresden, Sachsen, Germany.

How many employees does Seamless Therapeutics have?

Seamless Therapeutics is in the 11-50 employee band.

How does Seamless Therapeutics' funding compare to other Biotechnology startups?

Seamless Therapeutics' latest round of $12.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Seamless Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seamless Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.